Zobrazeno 1 - 10 of 294 pro vyhledávání: '"I, Ertenli"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
POS0765 IS THERE ANY DIFFERENCE IN THE CLINICAL FEATURES AND OUTCOMES OF PROLIFERATIVE AND NON-PROLIFERATIVE FORMS OF LUPUS NEPHRITIS PROVEN BY BIOPSY?
Autor: E. Duran, T. Yildirim, A. Taghiyeva, E. Bilgin, M. Arici, A. Saglam, S. Özen, M. Üner, Y. Erdem, U. Kalyoncu, A. I. Ertenli
Publikováno v: Annals of the Rheumatic Diseases. 81:669-670
BackgroundLupus nephritis (LN), which occurs in 60-70% of patients with systemic lupus erythematosus, is a major determinant of morbidity and mortality. There still are many uncertain aspects in clinical, pathological, and prognostic characteristics
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c92633a8828cf0f30975daac5fae15f
https://doi.org/10.1136/annrheumdis-2022-eular.3814
Zobrazit plný text záznamu
3
AB0774 Paradoxical reactions, especially psoriasis in rheumatology patients receiving biologic therapy from the Treasure database: a 5-year follow-up study
Autor: B. Yağiz, N. Lermi, B. N. Coşkun, E. Dalkiliç, S. Kiraz, A. İ. Ertenli, E. Bilgin, R. Yilmaz, A. Ateş, A. Tufan, R. Mercan, H. Cinakli, S. Akar, T. Kaşifoğlu, S. M. Türk, E. Gönüllü, A. Erden, C. Bes, H. Emmungil, U. Kalyoncu, Y. Pehlivan
Publikováno v: Annals of the Rheumatic Diseases. 81:1513-1514
BackgroundBiologic agents have altered our ability to treat chronic inflammatory diseases effectively. Although paradoxical reactions (PRs) were initially described with TNF-α inhibitors, they have been reported with newly developed biologic agents
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6dce4f521becde704febc08ea6d1649c
https://doi.org/10.1136/annrheumdis-2022-eular.4439
Zobrazit plný text záznamu
4
POS1008 FACTORS ASSOCIATED WITH HIP INVOLVEMENT AND ITS IMPACT ON TREATMENT DECISION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; TREASURE EXPERIENCE
Autor: E. Durak Ediboglu, U. Kalyoncu, D. Solmaz, T. Kaşifoğlu, E. Tekgoz, C. Bes, A. Erden, B. Yağiz, N. A. Kanitez, A. İ. Ertenli, B. N. Coşkun, R. Mercan, S. Kiraz, V. Yazisiz, O. Küçükşahin, A. Ateş, R. Yilmaz, Y. Pehlivan, H. Emmungil, N. S. Yasar Bilge, G. Kimyon, E. D. Ersözlü, E. Dalkiliç, S. S. Koca, S. Akar
Publikováno v: Annals of the Rheumatic Diseases. 81:812.2-813
BackgroundAxial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease affecting sacroiliac joints, spine and peripheral joints. In addition to spinal and peripheral manifestations, root joints (hip or sholder) involvement may also dev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a65de3a71d7968cda261035d7f6e630
https://doi.org/10.1136/annrheumdis-2022-eular.4962
Zobrazit plný text záznamu
5
POS0977 ASSOCIATION OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AXIAL SPONDYLOARTHRITIS WITH THE M694V MUTATION
Autor: M. Kiraci, E. Bilgin, E. Duran, B. Farisogullari, E. C. Bolek, G. K. Yardimci, Z. Özsoy, G. Ayan, G. Sandal Uzun, T. H. Akbaba, B. B. Peynircioglu, O. Karadag, A. Akdoğan, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu, L. Kiliç
Publikováno v: Annals of the Rheumatic Diseases. 81:797.1-797
BackgroundThe incidence of co-occurrence of FMF and axial spondyloarthritis (axSpA) in adults is reported to be 0.5-7.5%. M694V mutation is the most frequent variant in patients with FMF+AxSpA (1).ObjectivesTo evaluate the association of demographic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6992e778a7c3b037c09322c4221a20ad
https://doi.org/10.1136/annrheumdis-2022-eular.2414
Zobrazit plný text záznamu
6
AB0353 bDMARD CHOICES FOR INFLAMMATORY ARTHRITIS WITH CHRONIC KIDNEY DISEASE; HUR-BIO REAL-LIFE REGISTRY
Autor: G. Sandal Uzun, A. Taghiyeva, İ. Y. Çakir, K. Moral, E. Bilgin, G. K. Yardimci, B. Farisogullari, E. C. Bolek, E. Duran, Z. Özsoy, G. Ayan, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu
Publikováno v: Annals of the Rheumatic Diseases. 81:1303.1-1303
BackgroundRheumatic disesases may involve multiple systems and chronic kidney disease (CKD) can be seen during the course of diseases. Accompanying CKD affects the the choice of treatments in patients with rheumatic disease. There is limited data on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::863b5f8be08e0f9a675f13c039266f8d
https://doi.org/10.1136/annrheumdis-2022-eular.2474
Zobrazit plný text záznamu
7
AB1076 IS THERE AN ADDITIONAL IMPACT OF STIMULATING CD8+ LYMPHOCYTES TO DETECT LATENT TUBERCULOSIS IN PATIENTS WITH RHEUMATIC DISEASES?
Autor: Z. Özsoy, A. Özdemir, M. Ekici, A. Eken, F. Çakmak, E. Bilgin, L. Kiliç, A. İ. Ertenli, Z. Saribaş, O. Karadag, B. Şener
Publikováno v: Annals of the Rheumatic Diseases. 81:1658.2-1658
BackgroundPurified protein derivative skin test (PPD) or interferon gamma release assays (IGRAs) are used as diagnostic tools to detect latent tuberculosis. QuantiFERON-TB Gold Plus (QFT-Plus) is a new test that detects latent tuberculosis. Antigens
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::033c56aa1bb8db9293221ea8da05c285
https://doi.org/10.1136/annrheumdis-2022-eular.3924
Zobrazit plný text záznamu
8
AB0282 COMORBIDITIES ARE MORE IMPORTANT THAN JAK INHIBITORS: VENOUS THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS
Autor: G. Sandal Uzun, M. Bahap, O. Yucel, Y. Kaygusuz, E. Bilgin, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu
Publikováno v: Annals of the Rheumatic Diseases. 81:1267.2-1268
BackgroundThe risk of Venous thromboembolisim (VTE) is increased and is an important cause of mortality and morbidity in rheumatoid arthritis. In addition to the underlying Rheumatoid arthritis(RA), there are a number of predisposing risk factors for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9dea3756a0c54f0a2ce0b8593b9d2b8
https://doi.org/10.1136/annrheumdis-2022-eular.3084
Zobrazit plný text záznamu
9
AB0940 Is psoriatic arthritis really seronegative?
Autor: G. Ayan, N. E. Gezerer, E. Bilgin, G. K. Yardimci, E. C. Bolek, B. Farisogullari, E. Duran, Z. Özsoy, G. Sandal Uzun, M. Ekici, E. Unaldi, L. Kiliç, A. Akdogan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu
Publikováno v: Annals of the Rheumatic Diseases. 81:1598.2-1599
BackgroundPsoriatic Arthritis (PsA) is a heterogeneous disease classified as a seronegative group of inflammatory arthritis.ObjectivesOur aim was to understand the real-life seropositivity rates for commonly used autoantibodies in rheumatology practi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96188e456cd39abe1baea15d80421a33
https://doi.org/10.1136/annrheumdis-2022-eular.2977
Zobrazit plný text záznamu
10
POS0991 PREDICTORS OF DEVELOPMENT OF ADVANCED SPINAL ANKYLOSIS/BAMBOO SPINE IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM REAL-LIFE DATA
Autor: B. Farisogullari, G. K. Yardimci, E. Bilgin, E. C. Bolek, E. Duran, G. Ayan, Z. Özsoy, G. Sandal Uzun, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, U. Kalyoncu, A. İ. Ertenli
Publikováno v: Annals of the Rheumatic Diseases. 81:803.2-804
BackgroundIn axial spondyloarthritis (axSpA), intervertebral ossification bridges of consecutive vertebrae may progress to advanced spinal ankylosis and bamboo spine over the years [1].ObjectivesTo identify demographic, clinical, disease activity and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c571e37aaa1a78fa9b86d5d68d47de5f
https://doi.org/10.1136/annrheumdis-2022-eular.3661
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje